The European Medicines Agency (EMA) has established an infrastructure to support the monitoring of the efficacy and safety of COVID-19 treatments and vaccines in daily clinical practice. Three contracts for observational research have been signed with academic and private partners, to be ready to effectively monitor vaccines in the real world as soon as they are authorised and support the safe and effective use of COVID-19 vaccines and medicines.
Learn more about projects supporting real-world monitoring of COVID-19 treatments and vaccines.
for articles/videos/studies
Healthcare professionals who wish to be part of a unique network, providing access to up-to-date, accurate and validated information about clinical research.
Investigators and study staff who wish to be part of a unique network, in order to stay abreast of clinical trials taking place in Luxembourg and who are willing to further develop their competencies.
